Economic analysis of hyperbaric oxygen therapy for... (2024 study) Skip to main content
RCT Diving and hyperbaric medicine 2024

Economic analysis of hyperbaric oxygen therapy for the treatment of ischaemic diabetic foot ulcers.

Brouwer RJ, van Reijen NS, Dijkgraaf MG, Hoencamp R, Koelemay MJ, van Hulst RA, et al., Diving and hyperbaric medicine, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers compared the costs and health outcomes of adding hyperbaric oxygen therapy (HBOT) to standard care against standard care alone for diabetic foot ulcers with poor blood supply, using data from a randomised trial.

What They Found

In this economic analysis of the DAMO2CLES randomised trial, adding HBOT to standard care showed no significant difference in costs, limb salvage or health status compared with standard care alone over 12 months. The trial included 120 patients, with 60 given HBOT plus standard care and 60 given standard care. The cost difference was not significant, and the cost per limb saved was an ICER of 37,912 euros, with a very wide confidence interval from minus 112,188 to 1,063,561 euros. Average quality-adjusted life years were 0.54 with HBOT plus standard care and 0.56 with standard care alone, a difference that was not significant. For Wagner stage III/IV ulcers, the authors reported a trend toward better effectiveness and cost-effectiveness, while HBOT showed no benefit for Wagner stage II.

What This Means for Canadian Patients

For people with ischaemic diabetic foot ulcers, this study found no significant gains in limb salvage or health status from adding HBOT to standard care, and no significant cost difference. The Wagner stage III/IV trend was described as a trend only, and the abstract did not report it as a confirmed benefit. Patients can discuss these findings with their care team.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The confidence intervals for the cost and cost-effectiveness results were very wide and included zero or negative values, and the Wagner stage subgroup findings were only a trend, so the study could not show clear differences.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Wound Care
Source Pubmed
PubMed ID 39675733
Year Published 2024
Journal Diving and hyperbaric medicine
MeSH Terms Hyperbaric Oxygenation; Humans; Diabetic Foot; Cost-Benefit Analysis; Quality-Adjusted Life Years; Male; Female; Aged; Middle Aged; Limb Salvage; Ischemia; Standard of Care; Health Status

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology